Comments

MediPharm Labs (MEDIF) Stock Price, Quote, News & History

MEDIFOTCQB
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
At close: Dec 16, 4:00 PM EST

Overview

NewsEarningsShort Interest

Key Statistics

Open
$0.04
Close
-
Volume / Avg.
187.28K / 174.03K
Day Range
$0.04 - $0.05
52 Wk Range
0.04 - 0.09
Market Cap
$21.58M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

Recent Medipharm Labs Corp News

This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago

Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap.
Javier Hasse

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
Javier Hasse

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024 was a major step in the right direction towards profitability," Greg Hunter, the company's CFO, said. "Paying off our debt and rationalizing facilities, pursuing cost efficiencies while growing our higher margin international revenues are all critical elements to position us for long-term sustainable growth."
Jelena Martinovic

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Key Statistics

Open
$0.04
Close
-
Volume / Avg.
187.28K / 174.03K
Day Range
$0.04 - $0.05
52 Wk Range
0.04 - 0.09
Market Cap
$21.58M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Pharmaceuticals
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and wh...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MEDIF

FAQ

Q

How do I buy MediPharm Labs (MEDIF) stock?

A

You can purchase shares of MediPharm Labs (OTCQB:MEDIF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are MediPharm Labs (MEDIF) competitors?

A

There are no as such competitors for MediPharm Labs.

Q

What is the forecast, or price target, for MediPharm Labs (MEDIF) stock?

A

There is no analysis for MediPharm Labs to provide a consensus price target.

Q

What is the current price for MediPharm Labs (MEDIF)?

A

The stock price for MediPharm Labs (OTCQB: MEDIF) is $0.0513 last updated December 16, 2025 at 3:38 PM EST.

Q

Does MediPharm Labs (MEDIF) pay a dividend?

A

There are no upcoming dividends for MediPharm Labs.

Q

When is MediPharm Labs (OTCQB:MEDIF) reporting earnings?

A

MediPharm Labs does not have any upcoming earnings scheduled.

Q

Is MediPharm Labs (MEDIF) going to split?

A

There is no upcoming split for MediPharm Labs.

Q

What sector and industry does MediPharm Labs (MEDIF) operate in?

A

MediPharm Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved